GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OCX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for OncoCyte Corp
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Loss -1.16% PDF

The OncoCyte Corp stock price fell by -1.16% on the last day (Thursday, 18th Apr 2024) from $2.59 to $2.56. During the last trading day the stock fluctuated 6.83% from a day low at $2.49 to a day high of $2.66. The price has fallen in 6 of the last 10 days and is down by -12.93% for this period. Volume has increased on the last day by 933 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 37 thousand shares were bought and sold for approximately $93.90 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.52 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.77% during the next 3 months and, with a 90% probability hold a price between $2.30 and $2.79 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OCX Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 1.19%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The OncoCyte Corp stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.72 and $2.93. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). OncoCyte Corp gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for OncoCyte Corp stock

OncoCyte Corp finds support from accumulated volume at $2.53 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.170 between high and low, or 6.83%. For the last week, the stock has had daily average volatility of 13.06%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OCX) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect OncoCyte Corp to open at $2.57, and during the day (based on 14 day Average True Range), to move between $2.40 and $2.72, which gives a possible trading interval of +/-$0.159 (+/-6.23%) up or down from last closing price. If OncoCyte Corp takes out the full calculated possible swing range there will be an estimated 12.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.53 (1.17%) than the resistance at $2.71 (5.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is OncoCyte Corp stock A Buy?

OncoCyte Corp holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.599 Sell Candidate Unchanged

Predicted Opening Price for OncoCyte Corp of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$2.57 ( 0.391%) $2.56

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OCX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.74 7.03 %
R2 2.68 4.49 %
R1 2.63 2.93 %
Current price: 2.56
Support S1 2.51 -2.15 %
S2 2.46 -3.71 %
S3 2.40 -6.25 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.00 17.19 %
R2 2.75 7.42 %
R1 2.71 5.86 %
Current price 2.56
Support S1 2.53 -1.17%
S2 0 .
S3 0 .

FAQ

What is the symbol for OncoCyte Corp Stock and on which exchange is it traded?
The symbol for OncoCyte Corp is OCX and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell OncoCyte Corp Stock?
OncoCyte Corp holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy OncoCyte Corp Stock?
OncoCyte Corp Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy OncoCyte Corp Stock.

What's the current price of OncoCyte Corp Stock?
As of the end of day on the 2024-04-18, the price of an OncoCyte Corp (OCX) share was $2.56.

What is the 52-week high and low for OncoCyte Corp Stock?
The 52-week high for OncoCyte Corp Stock is $4.61 and the 52-week low is $0.190.

What is the market capitalization of OncoCyte Corp Stock?
As of the 2024-04-18, the market capitalization of OncoCyte Corp is 21.179M.

When is the next earnings date for OncoCyte Corp?
The upcoming earnings date for OncoCyte Corp is May 09, 2024.
Click to get the best stock tips daily for free!

About OncoCyte Corp

OncoCyte OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support... OCX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT